Additional file 1: Survey questions. (i) In your local
Recommend Documents
Nicotine gum. ___ Covered for general enrollment. ___ Covered for some contracts. ___ Covered with cessation program. ___ Not covered. ___ On formulary.
[Not at all â To a great extent]. 9. How has your organization communicated stroke QBPs implementation as a priority? (Select all that apply) a. Through its ...
Solvent was evaporated in vacuo, and the residue was dissolved in AcOEt and ... Purification was accomplished by chromatography with AcOEt/hexane mixture ...
Fox BD [170]. 2012 BMJ. 3. ... Lopez-Olivo MA [183]. 2012 JAMA .... review and meta-analysis of randomised trials. BMJ. 2017;358:j3887. 17. Batelaan NM .... Khera R, Murad MH, Chandar AK, et al. ..... Keene D, Price C, Shun-Shin MJ, et al.
pressure (mmHg). Yes/No. Heart rate per minute. Yes/No. Consciousness. Yes/No. Oxygenation: NRM. Ventimask O2-glasses. None. Oxygen in liters per minute ...
Typhoid. Decoction of a mixture of the roots and leaves is taken orally. ..... kamerunensis is orally. Raphia hookeri Man. & Wendl. Arecaceae Kho. Sap. Induces.
16 moderate phenotype. 0. 19. 19. 2 weak phenotype. 0. 25. 5. 1 normal. 8. 45. 8. 0 phenotypes in surviv. 0%. 71%. 92%. 100%. Tcf3. P. N. A. Tcf3. MO. Tcf3. kP.
Abbreviations used: AD = Alzheimer's disease; BMI = body mass index; SD = standard deviation; T2DM = Type 2 diabetes mellitus; examination parameter total ...
Institute for Biomedical Technologies, CNR, Bari, Italy. 7 Laurent ... Instituto Gulbenkian de Ciencia, Centro Portugues de Bioinformatica, Oeiras, Portugal.
alan in e arach id ic acid arach id o n ic acid arg in in e asco rb ate asp arag in e asp artate β. -alan in e β. -h y d ro x y b u ty rate b is-m o n o stearin b u tan o.
Similar to sulfate transporter [Arabidopsis thaliana], partial. 0.0052. 2.69. VVCCGC2069C05.b1 Similar to outward-rectifying potassium channel KCO1 ...
folder holding the TIFF microscopy images and an output folder for the generated data can be selected. The 'White', 'Red' and 'Green' fluorescence microscopy ...
Additional file 1. A. B. 250. 148. 98. 64. 50. 36. kDa m o c k. T. R. P. M. 5 β-actin. TRPM5 dimer monomer b rig h tfie ld flu o re s ce n c e. HEK293 parental line.
7) The law shall accord special protection to orphans and other vulnerable children. Ch.4. Art.45. Human rights and freedoms additional to other rights;.
Search Procedure for the Systematic. Review. Databases used for Initial Search. Ovid MEDLINE (R) In-Process and other Non-Indexed Citations (January 17th.
General Procedure for Peptide Coupling (GP 1): HOBt (2.6 mmol), Et3N (3.0 mmol), DCC (2.6 mmol), and. DMAP (0.1 mmol) were sequentially added to a stirred ...
... but are for other purposes. ... you were in several categories within a year then just tick them all. If you were ... How well do the following statements describe your working environment? Definitely .... the two to best describe yourself. +++ +
GGATAAGAGCGGCACAAGGA. GAAGGGCGAGATTGGAATGA. F 53.8. 55. [4]. R 51.8. 50. LIP. GGCCTCAAAGCCACCAGTAC. GGCAGTGCACATGTTGCAG.
Fat body Structures and expression of mRNAs coding for major plasma proteins of Bombyx mori. Sakai N., Mori S., Izumi S., Haino-Fukushima K.,. Ogura T.
Additional file 1: Survey questions. (i) In your local
Select all that apply. Direct access via GP referral. Choose-and-book system. (iii) On average, how long does it take a person with tinnitus to reach the tinnitus.
Additional file 1: Survey questions.
(i)
In your local service, what is the standard referral pathway for people with tinnitus? Please number only the applicable options through the steps in the patient journey. Number them so that 1 = the first step, 2 = the next step, and so on. ____ GP ____ Audiology (hospital setting) ____ Audiology (community setting) ____ ENT specialty ____ Clinical psychology ____ Other medical specialty
(ii)
How do tinnitus patients access your ENT/audiology service from their GP? Select all that apply. Direct access via GP referral Choose-and-book system
(iii)
On average, how long does it take a person with tinnitus to reach the tinnitus specialist in your ENT/audiology service? Less than 4 weeks More than 4 but less than 8 weeks More than 8 but less than 12 weeks More than 12 but less than 16 weeks More than 16 weeks
(iv)
Based on the referrals that you receive, how appropriately/effectively do you believe your local GPs manage people with tinnitus? _________________________________________________________ I do not feel able to comment (additional tick box)
(v)
Do you have the option to refer your tinnitus patients to other disciplines that offer a range of treatments? Select all that apply. Medical Surgical Rehabilitative Psychological Psychiatric
(vi)
Do you have the option to refer your tinnitus patients to a clinical psychologist or other specialist outside the ENT/audiology service who is qualified in providing psychological therapy? Yes/No
(vii)
What longer-term support networks are available locally? _________________________________________________________
(viii)
What do you consider as the main challenge for implementing an efficient referral pathway for tinnitus care across different levels of your NHS network? _________________________________________________________ Do no feel able to comment (additional tick box) No challenge (additional tick box)
(ix)
From your point of view, how appropriate/effective is the referral process to and from your service for people whose primary complaint is tinnitus? _________________________________________________________ I do no feel able to comment (additional tick box)
(x)
What do you consider has been the main impact of the 18-week commissioning pathway? _________________________________________________________ Do not understand the pathway in enough detail to comment (additional tick box) No impact (additional tick box)
(xi)
Has the management of patient appointments in your service changed as a result of the 18-week commissioning pathway? Yes No Not sure